Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report.
Kristian AssingChristian NielsenMarianne JakobsenCharlotte B AndersenKristin SkogstrandShahin GainiBirgitte PreissSussi Bagge MortensenMarianne Nielsine SkovLine Dahlerup RasmussenPublished in: BMC infectious diseases (2020)
To the best of our knowledge, this is the first report of elevated CD4+ IL-21+ T cell frequencies in human EBV disease. IL-21 overproduction may, apart from driving T cell mediated anti-EBV responses, disrupt germinal center derived memory B cell and plasma cell formation, and thereby contribute to EBV disease control.